课题基金 / 基金详情

Anakinra for neutrophilic pustular skin disease

Anakinra for neutrophilic pustular skin disease
阿那白滞素（Anakinra）治疗中性粒细胞性脓疱性皮肤病
批准号：
8938186
负责人：
Edward Cowen
金额：
$28.08万
依托单位：
DIVISION OF BASIC SCIENCES - NCI
依托单位国家：
美国
项目类别：
财政年份：
--
资助国家：
美国
项目状态：
未结题
起止时间：
至
来源：
https://reporter.nih.gov/project-details/8938186
关键词：
ClinicalCollaborationsDiseaseEnrollmentGoalsInterleukin-1LaboratoriesOutcomePET/CT scanPathway interactionsPatientsProtocols documentationPustular psoriasisSamplingSerumTherapeuticTissuesTreatment Protocolsanakinracardiovascular disorder riskdesignskin disorder

项目摘要

项目成果

Edward Cowen的其他基金

相似基金

相关文献

中文摘要
翻译
迄今为止，已有8名患者接受了这种治疗方案。25-30例患者的目标是确定阿那金对脓疱性嗜神经性皮肤病是否有效。除临床结果外，组织和血清样本将被送往Raphaela Goldbach-Mansky、Maria Morasso、Alison McBride和Nehal Mehta的实验室，以进一步研究脓疱性银屑病的生物学途径，包括通过PET/CT评估的心血管疾病风险。
英文摘要
To date, eight patients have enrolled on this treatment protocol. A goal of 25-30 patients has been established to determine if anakinra has efficacy for pustular neurtrophilic skin disease. In addition to the clinical outcomes, tissue and serum samples are being sent to the lab of Raphaela Goldbach-Mansky, Maria Morasso, Alison McBride, and Nehal Mehta in order to further investigate the biologic pathways responsible for pustular psoriasis, including risk of cardiovascular disease as assessed by PET/CT.
期刊论文(0)
专著(0)
科研奖励(0)
会议论文
Chronic graft-versus-host disease
Dermatology Consultation Service
Dermatology Consultation Service
Dermatology Consultation Service
海外基金